Skip Navigation

European Heart Journal 1986 7(1):54-60;
Copyright © 1986 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by TWEDDEL, A. C.
Right arrow Articles by HUTTON, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TWEDDEL, A. C.
Right arrow Articles by HUTTON, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 The European Society of Cardiology

Felodipine in ventricular dysfunction

A. C. TWEDDEL and I. HUTTON

University Department of Medical Cardiology, Royal Infirmary Glasgow, U.K.

Received 8 May 1985; revised 25 July 1985; .

Dr I. Hutton, Royal Infirmary, 10 Alexandra Parade, Glasgow, G31 2ER, Scotland.

Abstract

The systemic and coronary haemodynamic effects of felodipine were evaluated at rest and during stress induced atrial pacing in fourteen patients with chronic cardiac failure, secondary to coronary heart disease. Felodipine was an effective arteriolar vasodilator producing increases in cardiac index from 2.6 ± 0.l to 3.5 ± 0.2 l min–1 m–2 (P<0.001) and stroke volume 35.3 ± 2.7 to 41.4 ± 2.4 ml beat–1 m–2 (P<0.002).

Coronary venous flow also increased significantly (126 ± 8 to 168 ± 13 ml min–1) (P<0.005) and this did not appear to be accompanied by an increase in myocardial oxygen usage, as myocardial oxygen consumption was essentially unchanged. When the myocardium was stressed by atrial pacing the increase in cardiac output and stroke volume was maintained—25% and 23%, respectively (P<0.01). These results suggest that felodipine may well have a significant role in the management of patients with congestive cardiac failure.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.